A transporter’s doom or destiny: SLC6A1 in health and disease, novel molecular targets and emerging therapeutic prospects

Overview of attention for article published in Frontiers in Molecular Neuroscience, August 2024

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

So far, Altmetric has seen 16 X posts from 13 X users, with an upper bound of 86,367 followers.

RT @FrontNeurosci: New Research: A transporter’s doom or destiny: SLC6A1 in health and disease, novel molecular targets and emerging therap…

RT @FrontNeurosci: New Research: A transporter’s doom or destiny: SLC6A1 in health and disease, novel molecular targets and emerging therap…

RT @FrontNeurosci: New Research: A transporter’s doom or destiny: SLC6A1 in health and disease, novel molecular targets and emerging therap…

RT @FrontNeurosci: New Research: A transporter’s doom or destiny: SLC6A1 in health and disease, novel molecular targets and emerging therap…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 12 additional X posts.